Giulia Bianchi
Impact in
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 80
- HER2/EGFR in Cancer Research 39
- Cancer Treatment and Pharmacology 26
- Cancer Cells and Metastasis 9
- Cancer Immunotherapy and Biomarkers 9
-
- Advanced Breast Cancer Therapies 30
- Co-authors
- Luca Gianni (15 shared papers)Graham Ross (5 shared papers)Semiglazov Vf (6 shared papers)Aňa Lluch (7 shared papers)Pinuccia Valagussa (11 shared papers)Tadeusz Pieńkowski (9 shared papers)Young‐Hyuck Im (8 shared papers)Ling‐Ming Tseng (7 shared papers)
- Journals
- Journal of Clinical Oncology (22 papers)Annals of Oncology (19 papers)Cancer Research (5 papers)Clinical Breast Cancer (4 papers)The Breast (4 papers)
- Partner nations
- ItalySpainUnited States
In The Last Decade
Giulia Bianchi
120 papers receiving 6.0k citations
Giulia Bianchi's Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 4.8k
- Cancer Research 2.2k
- Radiology, Nuclear Medicine and Imaging 1.8k
- Pulmonary and Respiratory Medicine 1.6k
- Genetics 435
Countries citing papers authored by Giulia Bianchi
This map shows the geographic impact of Giulia Bianchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Bianchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Bianchi more than expected).
Fields of papers citing papers by Giulia Bianchi
This network shows the impact of papers produced by Giulia Bianchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Bianchi. The network helps show where Giulia Bianchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Giulia Bianchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial Hit paper breakdown → | 2011 | 1535 |
| 2 | 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial Hit paper breakdown → | 2016 | 555 |
| 3 | Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer Hit paper breakdown → | 2009 | 504 |
| 4 | Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy Hit paper breakdown → | 2010 | 456 |
| 5 | 2013 | 302 | |
| 6 | 2007 | 194 | |
| 7 | 2010 | 187 | |
| 8 | 2012 | 182 | |
| 9 | Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival Hit paper breakdown → | 2021 | 161 |
| 10 | 2019 | 158 | |
| 11 | 2005 | 123 | |
| 12 | 2015 | 95 | |
| 13 | 2009 | 86 | |
| 14 | 2021 | 85 | |
| 15 | 2021 | 80 | |
| 16 | 2017 | 76 | |
| 17 | 2013 | 60 | |
| 18 | 2019 | 57 | |
| 19 | 2021 | 47 | |
| 20 | 2018 | 45 |
About Giulia Bianchi
Giulia Bianchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 127 papers that have together received 6.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (39 papers), Breast Cancer Treatment Studies (32 papers), Advanced Breast Cancer Therapies (30 papers), Cancer Treatment and Pharmacology (26 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Cancer Genomics and Diagnostics (15 papers), Cancer Cells and Metastasis (9 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Oncology (4.8k citations), Cancer Research (2.2k citations), Radiology, Nuclear Medicine and Imaging (1.8k citations), Pulmonary and Respiratory Medicine (1.6k citations) and Genetics (435 citations). Giulia Bianchi has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Luca Gianni, Graham Ross, Semiglazov Vf, Aňa Lluch, Pinuccia Valagussa, Tadeusz Pieńkowski, Young‐Hyuck Im, Ling‐Ming Tseng, Brigitte Poirier and Juan de la Haba-Rodríguez. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Clinical Breast Cancer and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.